CHATSWORTH, CalifJan. 3, 2002--Natrol, Inc. (Nasdaq:NTOL), a leading manufacturer and marketer of branded dietary supplements, today announced that it had appointed Vincent Andrich Vice President of Sales for its Prolab, Inc. sports nutrition division.
Mr. Andrich has had fifteen years of experience in the sports nutrition industry, and has held the posts of Vice President of Sports Nutrition at Weider Nutrition International, Senior Director of Sports Nutrition at EAS, and Senior Director of Marketing at MET-RX USA.
"Prolab has a rich tradition of providing quality products at a great value, earning the trust and respect of consumers everywhere," said Mr. Andrich when accepting his position. "I have been impressed with the people at Natrol and Prolab, and I look forward to joining them in significantly expanding Prolab's consumer base."
In addition to his executive-level business experience, Mr. Andrich has authored the 4th issue of the bestselling Sports Supplement Review, and has had articles published in Muscle, Fitness and Muscle Media magazines.
"General management, sales management, product development and marketing -- Vince has done it all with excellence," said Jon Denis, Vice President of Sales for Natrol, Inc., Prolab's parent company. "Prolab is already one of the top global brands, and Vince's expertise will only help us reach higher levels."
The statements made in this press release which are not historical facts including statements regarding expectations for future growth of revenue and profits are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. As a result of a number of factors that Natrol may not currently foresee, Natrol and Prolab's actual results could differ materially from those set forth in the forward-looking statements. Certain factors that might cause Natrol's actual results to differ materially from those set forth in the forward-looking statements are set forth under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 1999 and in the Company's other filings with the Securities and Exchange Commission.